Shenzhen Salubris Pharmaceuticals Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 15.85% vs 24.15% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 28.72% vs 18.67% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,110.30",
          "val2": "958.40",
          "chgp": "15.85%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "204.30",
          "val2": "266.10",
          "chgp": "-23.22%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "4.90",
          "val2": "4.30",
          "chgp": "13.95%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "1.90",
          "val2": "2.50",
          "chgp": "-24.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "216.00",
          "val2": "167.80",
          "chgp": "28.72%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "184.00%",
          "val2": "167.90%",
          "chgp": "1.61%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 19.18% vs -3.25% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 4.20% vs -8.45% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,975.50",
          "val2": "3,335.70",
          "chgp": "19.18%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,080.40",
          "val2": "927.50",
          "chgp": "16.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "17.70",
          "val2": "17.90",
          "chgp": "-1.12%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-143.00",
          "val2": "-42.60",
          "chgp": "-235.68%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "605.20",
          "val2": "580.80",
          "chgp": "4.20%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "168.90%",
          "val2": "165.50%",
          "chgp": "0.34%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY

Sep'25

Sep'24

Change(%)

Net Sales

1,110.30

958.40

15.85%

Operating Profit (PBDIT) excl Other Income

204.30

266.10

-23.22%

Interest

4.90

4.30

13.95%

Exceptional Items

1.90

2.50

-24.00%

Consolidate Net Profit

216.00

167.80

28.72%

Operating Profit Margin (Excl OI)

184.00%

167.90%

1.61%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Sep 2025 is 15.85% vs 24.15% in Sep 2024

Consolidated Net Profit

YoY Growth in quarter ended Sep 2025 is 28.72% vs 18.67% in Sep 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

3,975.50

3,335.70

19.18%

Operating Profit (PBDIT) excl Other Income

1,080.40

927.50

16.49%

Interest

17.70

17.90

-1.12%

Exceptional Items

-143.00

-42.60

-235.68%

Consolidate Net Profit

605.20

580.80

4.20%

Operating Profit Margin (Excl OI)

168.90%

165.50%

0.34%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 19.18% vs -3.25% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 4.20% vs -8.45% in Dec 2023

All Annual Results